Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07499128
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:29:02.927563+00:00
Published At
2026-04-24T00:00:00+00:00
Record Updated At
2026-04-24
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Cytokine Release Syndrome", "Neoplasms", "Lymphoma", "Precursor Cell Lymphoblastic Leukemia-Lymphoma", "Multiple Myeloma", "Lymphoma Mantle-cell", "Immunotherapy", "Cell and Tissue-Based Therapy", "Cytokines", "Monitoring Physiologic", "Immune Monitoring", "Wearable Electronic Devices", "Thermometry", "Body Temperature", "Antibodies Bispecific", "Receptors Chimeric Antigen"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-24"
protocolSection.identificationModule.nctId
"NCT07499128"
protocolSection.identificationModule.officialTitle
"Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Cytokine Release Syndrome (protocolSection.conditionsModule.conditions)
  • Neoplasms (protocolSection.conditionsModule.conditions)
  • Lymphoma (protocolSection.conditionsModule.conditions)
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (protocolSection.conditionsModule.conditions)
  • Multiple Myeloma (protocolSection.conditionsModule.conditions)
  • Lymphoma Mantle-cell (protocolSection.conditionsModule.conditions)
  • Immunotherapy (protocolSection.conditionsModule.conditions)
  • Cell and Tissue-Based Therapy (protocolSection.conditionsModule.conditions)
  • Cytokines (protocolSection.conditionsModule.conditions)
  • Monitoring Physiologic (protocolSection.conditionsModule.conditions)
  • Immune Monitoring (protocolSection.conditionsModule.conditions)
  • Wearable Electronic Devices (protocolSection.conditionsModule.conditions)
  • Thermometry (protocolSection.conditionsModule.conditions)
  • Body Temperature (protocolSection.conditionsModule.conditions)
  • Antibodies Bispecific (protocolSection.conditionsModule.conditions)
  • Receptors Chimeric Antigen (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.